SRINIVAS SRIDHAR NANOMEDICINE SCIENCE AND TECHNOLOGY CENTER NANOMEDICINE SCIENCE AND TECHNOLOGY CENTER ELECTRONIC MATERIALS RESEARCH INSTITUTE DEPARTMENT OF PHYSICS, NORTHEASTERN UNIVERSITY RADIATION ONCOLOGY , HARVARD MEDICAL SCHOOL www.igert.neu.edu
33
Embed
Sridhar...•MR, SPECT, CT, PET • Nanotechnologyinthe Operating Room of the Dental and Orthopedic Nanomedicine With Harvard School of Dental Medicine •Smart Implants for Bone Regeneration
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
SRINIVAS SRIDHARNANOMEDICINE SCIENCE AND TECHNOLOGY CENTERNANOMEDICINE SCIENCE AND TECHNOLOGY CENTER
ELECTRONIC MATERIALS RESEARCH INSTITUTE DEPARTMENT OF PHYSICS, NORTHEASTERN UNIVERSITY,RADIATION ONCOLOGY , HARVARD MEDICAL SCHOOL
www.igert.neu.edu
Director : Srinivas Sridhar, Ph.D.CAS Distinguished Professor of PhysicsDirector : Srinivas Sridhar, Ph.D.CAS Distinguished Professor of Physics
sagar.physics.neu.eduwww igert neu edu
Nanotechnology for Radiation OncologyNanotechnology for Radiation Oncology Magnetic Theranostic NanoplatformsMagnetic Theranostic Nanoplatforms
Visiting Professor of Radiation Oncology, Harvard Medical SchoolVisiting Professor of Radiation Oncology, Harvard Medical School
Funded by NIH, NSF, Hospitals
www.igert.neu.edu
With Harvard Medical School• Smart Implants for BIS‐IGRT• Gold Nanoparticles for Radiotherapy• Green Quantum Dots for Xray Photodynamic
With Harvard Medical School• Smart Implants for BIS‐IGRT• Gold Nanoparticles for Radiotherapy• Green Quantum Dots for Xray Photodynamic
Magnetic Theranostic Nanoplatforms• MR Contrast Enhancement• Magnetic Targeting• Magnetic Hyperthermia
Magnetic Theranostic Nanoplatforms• MR Contrast Enhancement• Magnetic Targeting• Magnetic Hyperthermia
TherapyTherapy
Multi‐modal Imaging Platforms• MR, SPECT, CT, PET• Nanotechnology in the Operating Room of the
Multi‐modal Imaging Platforms• MR, SPECT, CT, PET• Nanotechnology in the Operating Room of the
Dental and Orthopedic NanomedicineWith Harvard School of Dental Medicine•Smart Implants for Bone Regeneration •Slow release agents for cements and
Dental and Orthopedic NanomedicineWith Harvard School of Dental Medicine•Smart Implants for Bone Regeneration •Slow release agents for cements and• Nanotechnology in the Operating Room of the
Future• Nanotechnology in the Operating Room of the Future
•Slow release agents for cements and membranes•Slow release agents for cements and membranes
Nanoparticles in k l
MR Imaging of Theranostic Magnetic
www.igert.neu.edu
skin using multi‐modal imaging
Theranostic Magnetic Nanoiposomes
www.igert.neu.edu
From nano to micro
NNATUR
DNA base DNA turn Protein Virus CellsBacteria
RAL
1nm 10nm 100nm m0.1nm m
Metal MIcelleNanoassembly Liposome
DNA t h
SYNT
16nm4nm
DNA nanotechTHETI
www.igert.neu.edu
IC
Designing Utili k l d fDesigning Nano: The
computation revolution
• Utilize knowledge of interactions to design nanoelements
e o ut o
Making Nano: The
nanofabricatio n revolution
• Top‐down nanolithograpjy• Bottom up Self – assembly
Seeing Nano: The imaging revolution
• Atomic, Electron Microscopies
• Optical microscopies, d
www.igert.neu.edu
quantum dots
NANOMEDICINE A di i di i d th
NANOMEDICINE
A new paradigm in diagnosis and therapy
NANOTECHNOLOGY:NANOMATERIALS, NANOFABRICATION
GENOMICS, PROTEOMICS, MOLECULAR BASIS OF
DISEASE
Early Early Detection
NANOFABRICATION DISEASE
Diagnostics!
Targeted
yTargeted delivery of multiple therapies
Targeted DeliveryReal‐time efficacy assessments
Symptomatic management
www.igert.neu.edu
ARTISTS CONCEPTIONS OF AARTISTS CONCEPTIONS OF A FANTASTIC FUTURE FOR NANOMEDICINE
NANOBOTS TO CLEAN ARTERIES
NANOHUMVEES TO
Tim Fonseca
DESTROY TUMOR CELLS
www.igert.neu.edu
NANOMEDICINE
NANOTECHNOLOGY APPLIED TO:
•Cancer•Cardiovascular Diseases•Infectious Diseases•Orthopedics•Genomics•ProteomicsO th l l•Opthalmology
•Neuroscience•
www.igert.neu.edu
• ………..
THERANOSTIC NANOPLATFORMS
EARLY REAL‐TIME MONITORING
TARGETED
DIAGNOSTICS MONITORINGTHERAPY
www.igert.neu.edu
Figure: Opensource Handbook of Nanoscience and Nanotechnology
SENSING DRUG ELUTINGSENSING, DRUG ELUTING PLATFORMS, SCAFFOLDS AND
TEMPLATES, NEUROCHIP
Au or Fe‐Au NP1‐100nm
Micelles10‐50nm
Liposomes100‐250 nm
Polymeric NP~ 20nm – 10 m
SENSING TARGETING DELIVERY
www.igert.neu.edu
SENSING, TARGETING, DELIVERY
NANOPARTICLE FORMULATIONS OF DRUGS
www.igert.neu.edu
www.igert.neu.edu
Ferrari, Nature
Table 1. Examples of Nanomaterials in Clinical Use.* Nanomaterial Trade Name Application Target Adverse Effects Manufacturer Current Status
Examples of Nanomedicine in Clinical Use Kim, et. al. NEJM 2010
Nanomaterial Trade Name Application Target Adverse Effects Manufacturer Current Status Metallic Iron oxide Feridex MRI contrast Liver Back pain, vaso- Bayer Schering FDA approved
ical trials NanoTherm Cancer therapy Various forms Acute urinary MagForce In phase 3 clin-
retention ical trials Gold Verigene In vitro diag- Genetic Not applicable Nanosphere FDA approved
nostics Aurimmune Cancer therapy Various forms Fever CytImmune Sciences In phase 2 clin-
ical trials Nanoshells Auroshell Cancer therapy Head and neck Under investigation Nanospectra In phase 1 clin-
Biosciences ical trials Semiconductor
Quantum dot Qdots, EviTags, Fluorescent con- Tumors, cells, Not applicable Life Technologies, Research
semiconductor trast, in vitro tissues, and eBioscience, use only t l di ti l l Nnanocrystals diagnostics molecular Nanoco,
sensing CrystalPlex, structures Cytodiagnostics
Organic Protein Abraxane Cancer therapy Breast Cytopenia Abraxis Bioscience FDA approved Liposome Doxil/Caelyx Cancer therapy Various forms Hand–foot syndrome, Ortho Biotech FDA approved
stomatitisstomatitis Polymer Oncaspar Cancer therapy Acute lymphoblas- Urticaria, rash Rhône-Poulenc Rorer FDA approved
tic leukemia CALAA-01 Cancer therapy Various forms Mild renal toxicity Calando In phase 2 clin-
Vinblastine‐loaded MCLs improved melanoma treatment: in vivo therapeutic benefit
Mechanism of action:
Campbell , et. al.
Mechanism of action: Vinblastine sulfate- binds to the microtubular proteins of the mitotic spindle, causing mitotic arrest and cell
death
Magnet improvedTreatment outcomeTreatment outcome
www.igert.neu.edu
T1‐scan of healthy animal before and i di l f i j iimmediately after injection.
LiverLiver
Spleen
Melanoma tumor model
www.igert.neu.edu
Melanoma tumor modelMNL ARE LONG CIRCULATING AND CAN BE OBSERVED FOR > 48 HOURS
MAGNETIC LIPOSOMESMAGNETIC GUIDANCE LEADS TO INCREASED ACCUMULATION IN TUMNOR
T2‐scan of intravenous injected mouse with magnet
Magnet placed externally for 1 hour
T2‐scan of intravenous injected mouse with magnet applied for 1hr imaged 24 and 48 hours after injection.
Gultepe, et. al., Nanomedicine (2010)
www.igert.neu.edu
With Robert Campbell, Craig Ferris, Praveen Kulkarni
NANOMAGNETIC THERMAL THERAPY
MAGNETIC NANOPARTICLES ABSORB
THERMAL ABLATION > 45CCOAGULATION, NECROSIS
MAGNETIC NANOPARTICLES ABSORB ENERGY FROM AC MAGNETIC FIELDSRELEASE ENERGY TO TUMOR
NON INVASIVEHYPERTHERMIA 41‐45 CREVERSIBLE, SENSITIZATION
•NON‐INVASIVE •LOCALIZED •CAN BE IMAGED
NANOTECHNOLOGY AND NEWMAGNETIC SOURCES HAVE LED TO A REVIVALNANOTECHNOLOGY, AND NEW MAGNETIC SOURCES, HAVE LED TO A REVIVAL OF INTEREST IN MAGNETIC HYPERTHERMIACLINICAL TRIALS IN EUROPEDARTMOUTH CANCER NANOTECH CENTER ESTABLISHED
www.igert.neu.edu
IN VITRO HEATING USING MAGNETIC NANOLIPOSOMES
Hyperthermia of Mag C - Liposomes
110 0
20 mg/ml10 mg/ml5 mg/ml2 5 mg/ml
80 0
90.0
100.0
110.0
)
2.5 mg/mlBlank liposomes
50.0
60.0
70.0
80.0
pera
ture
(CRAPID TEMPERATURE
THERMAL ABLATION
20.0
30.0
40.0
50.0Te
mINCREASE WITH APPLICATION OF AC MAGNETIC FIELD360 kHz, 70 kA drive
HYPERTHERMIA
10.00 5 10 15 20 25 30
Time (minutes)
www.igert.neu.eduTHERMAL THERAPY FEASIBLE WITH MNL
BIOLOGICAL IN SITU IMAGE‐GUIDED RADIATION THERAPY (BIS‐IGRT)
Dual drug release strategies for localized delivery over 8 weeks
Brachytherapy spacers of IGRT coated with radiosensitizer-releasing nanoparticles, lead to a radiosensitized volume resulting in increased efficacy of radiation therapy.
Combined chemo + radiation therapy i ffi i t i ti ll